Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

FRX

Ferrex (FRX)

Ferrex
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FRX
DateTimeSourceHeadlineSymbolCompany
19/07/202221:30RNS Non-RegulatoryKeras Resources PLC Update regarding Investor Presentation and GMLSE:FRXFerrex
23/06/202200:20RNS Non-RegulatoryKeras Resources PLC New Date - Shareholder/Investor PresentationLSE:FRXFerrex
09/06/202216:03RNS Non-RegulatoryKeras Resources PLC Shareholder/Investor Meeting and PresentationLSE:FRXFerrex
24/06/202123:36RNS Non-RegulatoryKeras Resources PLC Updated Corporate PresentationLSE:FRXFerrex
30/10/201918:00RNS Non-RegulatoryKeras Resources PLC Joint Investor Event - Further DetailsLSE:FRXFerrex
14/09/201821:00RNS Non-RegulatoryKeras Resources PLC Investor EventLSE:FRXFerrex
24/11/201702:55RNS Non-RegulatoryKeras Resources PLC New Company PresentationLSE:FRXFerrex
16/11/201720:47RNS Non-RegulatoryKeras Resources PLC Pilbara Gold Presentation-London 23 November 2017LSE:FRXFerrex
01/08/201716:02RNS Non-RegulatoryKeras Resources PLC Brandon Hill ResearchLSE:FRXFerrex
12/04/201621:20RNS Non-RegulatoryKeras Resources PLC New Corporate PresentationLSE:FRXFerrex
18/03/201618:00RNS Non-RegulatoryKeras Resources PLC Corporate PresentationLSE:FRXFerrex
29/10/200920:54Dow Jones NewsRichter To Start Late Stage Tests On Key Schizophrenia DrugASX:FRXForest Laboratories Inc.
29/10/200919:47Dow Jones NewsHungary Richter, US Forest Announce Positive Drug TestsASX:FRXForest Laboratories Inc.
28/08/200908:31PR Newswire (US)Four Studies Published in The Lancet Show roflumilast (Daxas(R)), a New Oral Approach to COPD, Improves Lung Function and ReduceASX:FRX
19/08/200923:50Dow Jones News2nd UPDATE: Glenmark, Forest Say Their Drug Failed In TrialsASX:FRXForest Laboratories Inc.
19/08/200917:53Dow Jones NewsUPDATE: Glenmark, Forest Say Oglemilast Failed In Key StudyASX:FRXForest Laboratories Inc.
12/08/200918:32Dow Jones NewsAstraZeneca, Forest Labs Ink Ceftaroline DealASX:FRXForest Laboratories Inc.
10/08/200921:00PR Newswire (US)Nycomed and Forest Laboratories to Collaborate on US Commercialisation of Daxas(R) in COPDASX:FRX
21/07/200923:08Dow Jones NewsForest Labs 1Q Net Up 8.2% As Namenda Sales JumpASX:FRXForest Laboratories Inc.
22/06/200923:20PR Newswire (US)Beacon Equity Research on Stocks to Watch: Forest Labs, Harris, Philip Morris, IAMGOLD, Steel Dynamics and WyndhamASX:FRX
20/06/200904:40Dow Jones NewsForest Labs Reports Upbeat Pneumonia Drug Test ResultsASX:FRXForest Laboratories Inc.
11/06/200900:54Dow Jones NewsPHARMA MARKET: Wyeth Stands By Pristiq After Slow StartASX:FRXForest Laboratories Inc.
23/05/200906:34Dow Jones NewsDrug Makers To Pay $89 Million To Settle Alabama Medicaid Price SuitsASX:FRXForest Laboratories Inc.
06/05/200901:03Dow Jones News2nd UPDATE:Jubilant Organosys Unit In Pact With AstraZenecaASX:FRXForest Laboratories Inc.
30/04/200918:01Dow Jones NewsAlmirall, Forest See New Drug Application For COPD By 2012ASX:FRXForest Laboratories Inc.
21/04/200923:09Dow Jones NewsForest Labs 4Q Net Drops 46% Amid Marketing Probe Set-AsideASX:FRXForest Laboratories Inc.
04/04/200910:34Dow Jones NewsUPDATE: FDA Warns World's Largest Drug Firms Over Internet AdsASX:FRXForest Laboratories Inc.
04/04/200909:22Dow Jones NewsFDA Warns World's Largest Drug Firms Over Internet AdsASX:FRXForest Laboratories Inc.
06/03/200923:21Dow Jones NewsFDA Wants More Study On Almirall, Forest Labs COPD DrugASX:FRXForest Laboratories Inc.
26/02/200909:24Dow Jones NewsUPDATE:DOJ:Forest Labs Engaged In Improper Marketing,KickbacksASX:FRXForest Laboratories Inc.
 Showing the most relevant articles for your search:LSE:FRX